- April 25, 2017FCPA Violations – Only a Risk For Big Companies?
- April 19, 2017Investment Decisions for Investors and Entrepreneurs Considering 505(b)(2) Drug Applications
- October 27, 2016Keeping Your Competitive Advantage
- May 18, 2016The Robins Kaplan Tribal Litigation Update
- April 14, 2016Avoiding Drug Substance Patents and Exclusivities
- March 29, 2016Recent Legal & Economic Developments That Affect Your Biotech Business
- January 26, 2016A Look Back on Class Action Litigation Developments in 2015
- September 22, 2015The Digital Health Update
- September 21, 2015Cannabis in Indian Country: Recreational, Medical and Industrial Hemp
- June 2, 2015Minnesota Legislature Bolsters Sales Rep Termination Act
- May 19, 20155 Ways Retailers (and Others) Can Minimize Privacy and Data Breach Litigation
- April 21, 2015What Do You Do After the Verdict?
- April 14, 2015Cyber Risk Insurance
- April 7, 2015New Strategies for Venue in Hatch-Waxman Litigation
- March 24, 2015Winning Your Appeal in the Trial Court
- March 17, 2015Compiling Strategies for Protecting IP in Software
- March 3, 20155 Hidden Benefits of a Diverse Legal Team
- February 24, 2015Property Insurance Coverage
- February 17, 2015Balancing on the Tightrope of Today's Legal Profession
- February 10, 2015FDA Regulation of Mobile Medical Devices and Apps
- January 13, 2015Understanding and Managing Your "Natural" Litigation Risk
- January 6, 2015Strategic Considerations About Attorney-Client Privilege In Corporate Investigations
- December 16, 2014Women GCs: The Best Advice I Ever Received
- November 18, 2014Understanding the Stryker Settlement Program
- November 11, 2014How to Avoid the VirnetX Trap and Prove Your Patent Damages
- October 23, 2014Doing Business In an Age of Cyber Insecurity
- September 10, 2014How to Appeal to the Minnesota Court of Appeals Seminar
- September 10, 2014New Appellate Rules and Electronic Briefs Seminar
